On Friday, Ventyx Biosciences Inc (NASDAQ: VTYX) opened higher 9.00% from the last session, before settling in for the closing price of $8.0. Price fluctuations for VTYX have ranged from $0.78 to $10.55 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -87.13% over the past five years. Company’s average yearly earnings per share was noted 26.52% at the time writing. With a float of $64.07 million, this company’s outstanding shares have now reached $71.34 million.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ventyx Biosciences Inc is 10.22%, while institutional ownership is 62.14%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.
Ventyx Biosciences Inc (VTYX) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.41 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.55) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.89% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Check out the current performance indicators for Ventyx Biosciences Inc (VTYX). In the past quarter, the stock posted a quick ratio of 17.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (NASDAQ: VTYX) saw its 5-day average volume 2.89 million, a positive change from its year-to-date volume of 2.12 million. As of the previous 9 days, the stock’s Stochastic %D was 19.80%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 77.96%, which indicates a significant increase from 37.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.73 in the past 14 days, which was higher than the 0.43 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.81, while its 200-day Moving Average is $3.19. Nevertheless, the first resistance level for the watch stands at $9.20 in the near term. At $9.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.36. If the price goes on to break the first support level at $8.04, it is likely to go to the next support level at $7.36. The third support level lies at $6.88 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
There are currently 71,359K shares outstanding in the company with a market cap of 622.25 million. Presently, the company’s annual sales total 0 K according to its annual income of -135,120 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -22,830 K.
